Research on the Situation of Drug Pre-Approval Inspection and Response Strategy under the Requirements of New Laws and Regulations

Shi Haitao, Huang Xiaolong, Cheng Bin, Yang Jingpeng, He Benxia

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (3) : 243-252.

PDF(1007 KB)
PDF(1007 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (3) : 243-252. DOI: 10.16153/j.1002-7777.2024-10-0014
Supervision & Administration

Research on the Situation of Drug Pre-Approval Inspection and Response Strategy under the Requirements of New Laws and Regulations

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(3): 243-252 https://doi.org/10.16153/j.1002-7777.2024-10-0014

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1007 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉